Maccura Biotechnology Co.Ltd

¥9.06As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300463Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.18%)
Div yield —
ROE (0.70%)
Diagnostics & Research
Beta (5Y) 0.27
PE TTM —
TSR TTM (22.56%)
Mkt cap ¥5.478B
ROIC (0.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥9.45
4.33%
(5.92%)
Hold 9|3|8|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.10
0.09
0.09
7.62%
5.54%
(7.97%)
(14.17%)
Revenue¥M
254.7
258.5
259.1
259.3
5.41%
1.42%
2.99%
0.93%
Peers (US$821.2M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.549
0.441
0.415
EBIT/Intx
2.881
1.089
0.941
Own earn%
(6.07)
2.65
(3.30)
Sh yield%
35.40
15.41
12.81
Owners
Insiders/Inst%
4.85
81.13
Short interest%
0.94
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
27–32
$1 testx
—
Incr. ROIC%
7